- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Zhejiang Hisun Pharmaceutical Co. Ltd.
Headquarters: Taizhou City, Zhejiang, China
Website: http://www.hisunpharm.com
Year Founded: 1956
Status: Public
Industry Sector: HealthTechnology
CEO: Wei Hong Xiao
Number Of Employees: 8,062
Enterprise Value: $2,236,902,370
PE Ratio: -303.99
Exchange/Ticker 1: Shanghai:600267
Exchange/Ticker 2: N/A
Latest Market Cap: $1,336,098,692
BioCentury | Mar 18, 2020
Product Development
COVID-19 roundup: BioNTech, Pfizer co-developing vaccine, plus updates from Regeneron, Novartis, CureVac, Fujifilm and CanSino
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Nov 16, 2019
Product Development
Major multinationals open, close, open R&D centers in China
A timeline of moves by major multinationals to enter China's innovation ecosystem
BioCentury | Aug 16, 2019
Product Development
China’s biosimilars in fast lane
Guest Commentary: Why China's biosimilars market could take off faster than the U.S.'s and Europe's
BioCentury | May 31, 2019
Financial News
May 31 Financial Quick Takes: Mabpharm prices Hong Kong IPO; plus follow-ons from Amicus, Myovant and more
Items per page:
1 - 10 of 33